世界のヒトインスリンデリバリーシステム市場2021-2026：自動、手動

◆英語タイトル：Global Human Insulin Delivery System Market Growth 2021-2026
◆商品コード：LPI21MY9231
◆発行会社（リサーチ会社）：LP Information
◆発行日：2021年5月（※2024年版があります。お問い合わせください）
◆ページ数：166
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：医療装置
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥541,680	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥812,520	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,083,360	見積依頼/購入/質問フォーム

★LP Informationに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

LPインフォメーション社の「ヒトインスリンデリバリーシステムの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、自動、手動など、用途別には、病院、クリニック、ホームケアなどにセグメント区分してまとめました。ヒトインスリンデリバリーシステムのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・ヒトインスリンデリバリーシステムの世界市場概要（サマリー）
・ヒトインスリンデリバリーシステムの企業別販売量・売上
・ヒトインスリンデリバリーシステムの企業別市場シェア
・ヒトインスリンデリバリーシステムの世界市場規模 2016年-2021年：種類別（自動、手動）
・ヒトインスリンデリバリーシステムの世界市場規模 2016年-2021年：用途別（病院、クリニック、ホームケア）
・ヒトインスリンデリバリーシステムの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・ヒトインスリンデリバリーシステムのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・ヒトインスリンデリバリーシステムのヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・ヒトインスリンデリバリーシステムの中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・ヒトインスリンデリバリーシステム市場の成長要因・課題・動向
・ヒトインスリンデリバリーシステムの世界市場予測 2021年-2026年
・ヒトインスリンデリバリーシステムの南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・ヒトインスリンデリバリーシステムのアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・ヒトインスリンデリバリーシステムのヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・ヒトインスリンデリバリーシステムの中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・ヒトインスリンデリバリーシステムの世界市場予測：種類別（自動、手動）
・ヒトインスリンデリバリーシステムの世界市場予測：用途別（病院、クリニック、ホームケア）
・主要企業分析

【レポートの概要】

According to this latest study, the 2020 growth of Human Insulin Delivery System will have significant change from previous year. By the most conservative estimates of global Human Insulin Delivery System market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Human Insulin Delivery System market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Insulin Delivery System market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Automatic
Manual

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospitals
Clinics
Homecare

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
BD
Novo Nordisk
Medtronic
Sanofi
ELI Lilly and Company
Ypsomed Holding
Animas Corporation
Tandem Diabetes Care
Insulet Corporation
Biocon
Roche
Johnson & Johnson
Microport

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Insulin Delivery System Consumption 2016-2026
2.1.2 Human Insulin Delivery System Consumption CAGR by Region
2.2 Human Insulin Delivery System Segment by Type
2.2.1 Automatic
2.2.2 Manual
2.3 Human Insulin Delivery System Sales by Type
2.3.1 Global Human Insulin Delivery System Sales Market Share by Type (2016-2021)
2.3.2 Global Human Insulin Delivery System Revenue and Market Share by Type (2016-2021)
2.3.3 Global Human Insulin Delivery System Sale Price by Type (2016-2021)
2.4 Human Insulin Delivery System Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Homecare
2.5 Human Insulin Delivery System Sales by Application
2.5.1 Global Human Insulin Delivery System Sale Market Share by Application (2016-2021)
2.5.2 Global Human Insulin Delivery System Revenue and Market Share by Application (2016-2021)
2.5.3 Global Human Insulin Delivery System Sale Price by Application (2016-2021)

3 Global Human Insulin Delivery System by Company
3.1 Global Human Insulin Delivery System Sales Market Share by Company
3.1.1 Global Human Insulin Delivery System Sales by Company (2019-2021)
3.1.2 Global Human Insulin Delivery System Sales Market Share by Company (2019-2021)
3.2 Global Human Insulin Delivery System Revenue Market Share by Company
3.2.1 Global Human Insulin Delivery System Revenue by Company (2019-2021)
3.2.2 Global Human Insulin Delivery System Revenue Market Share by Company (2019-2021)
3.3 Global Human Insulin Delivery System Sale Price by Company
3.4 Global Manufacturers Human Insulin Delivery System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Insulin Delivery System Product Location Distribution
3.4.2 Players Human Insulin Delivery System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Human Insulin Delivery System by Region
4.1 Global Human Insulin Delivery System by Region
4.1.1 Global Human Insulin Delivery System Sales by Region
4.1.2 Global Human Insulin Delivery System Revenue by Region
4.2 Americas Human Insulin Delivery System Sales Growth
4.3 APAC Human Insulin Delivery System Sales Growth
4.4 Europe Human Insulin Delivery System Sales Growth
4.5 Middle East & Africa Human Insulin Delivery System Sales Growth

5 Americas
5.1 Americas Human Insulin Delivery System Sales by Country
5.1.1 Americas Human Insulin Delivery System Sales by Country (2016-2021)
5.1.2 Americas Human Insulin Delivery System Revenue by Country (2016-2021)
5.2 Americas Human Insulin Delivery System Sales by Type
5.3 Americas Human Insulin Delivery System Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Human Insulin Delivery System Sales by Region
6.1.1 APAC Human Insulin Delivery System Sales by Region (2016-2021)
6.1.2 APAC Human Insulin Delivery System Revenue by Region (2016-2021)
6.2 APAC Human Insulin Delivery System Sales by Type
6.3 APAC Human Insulin Delivery System Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Human Insulin Delivery System by Country
7.1.1 Europe Human Insulin Delivery System Sales by Country (2016-2021)
7.1.2 Europe Human Insulin Delivery System Revenue by Country (2016-2021)
7.2 Europe Human Insulin Delivery System Sales by Type
7.3 Europe Human Insulin Delivery System Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Human Insulin Delivery System by Country
8.1.1 Middle East & Africa Human Insulin Delivery System Sales by Country (2016-2021)
8.1.2 Middle East & Africa Human Insulin Delivery System Revenue by Country (2016-2021)
8.2 Middle East & Africa Human Insulin Delivery System Sales by Type
8.3 Middle East & Africa Human Insulin Delivery System Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Human Insulin Delivery System Distributors
10.3 Human Insulin Delivery System Customer

11 Global Human Insulin Delivery System Market Forecast
11.1 Global Human Insulin Delivery System Forecast by Region
11.1.1 Global Human Insulin Delivery System Forecast by Regions (2021-2026)
11.2.2 Global Human Insulin Delivery System Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Human Insulin Delivery System Forecast by Type
11.7 Global Human Insulin Delivery System Forecast by Application

12 Key Players Analysis
12.1 BD
12.1.1 BD BD Company Information
12.1.2 BD Human Insulin Delivery System Product Offered
12.1.3 BD Human Insulin Delivery System Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 BD Main Business Overview
12.1.5 BD Latest Developments
12.2 Novo Nordisk
12.2.1 Novo Nordisk Company Information
12.2.2 Novo Nordisk Human Insulin Delivery System Product Offered
12.2.3 Novo Nordisk Human Insulin Delivery System Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Novo Nordisk Main Business Overview
12.2.5 Novo Nordisk Latest Developments
12.3 Medtronic
12.3.1 Medtronic Company Information
12.3.2 Medtronic Human Insulin Delivery System Product Offered
12.3.3 Medtronic Human Insulin Delivery System Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Medtronic Main Business Overview
12.3.5 Medtronic Latest Developments
12.4 Sanofi
12.4.1 Sanofi Company Information
12.4.2 Sanofi Human Insulin Delivery System Product Offered
12.4.3 Sanofi Human Insulin Delivery System Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Sanofi Main Business Overview
12.4.5 Sanofi Latest Developments
12.5 ELI Lilly and Company
12.5.1 ELI Lilly and Company Company Information
12.5.2 ELI Lilly and Company Human Insulin Delivery System Product Offered
12.5.3 ELI Lilly and Company Human Insulin Delivery System Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 ELI Lilly and Company Main Business Overview
12.5.5 ELI Lilly and Company Latest Developments
12.6 Ypsomed Holding
12.6.1 Ypsomed Holding Company Information
12.6.2 Ypsomed Holding Human Insulin Delivery System Product Offered
12.6.3 Ypsomed Holding Human Insulin Delivery System Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Ypsomed Holding Main Business Overview
12.6.5 Ypsomed Holding Latest Developments
12.7 Animas Corporation
12.7.1 Animas Corporation Company Information
12.7.2 Animas Corporation Human Insulin Delivery System Product Offered
12.7.3 Animas Corporation Human Insulin Delivery System Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Animas Corporation Main Business Overview
12.7.5 Animas Corporation Latest Developments
12.8 Tandem Diabetes Care
12.8.1 Tandem Diabetes Care Company Information
12.8.2 Tandem Diabetes Care Human Insulin Delivery System Product Offered
12.8.3 Tandem Diabetes Care Human Insulin Delivery System Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Tandem Diabetes Care Main Business Overview
12.8.5 Tandem Diabetes Care Latest Developments
12.9 Insulet Corporation
12.9.1 Insulet Corporation Company Information
12.9.2 Insulet Corporation Human Insulin Delivery System Product Offered
12.9.3 Insulet Corporation Human Insulin Delivery System Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Insulet Corporation Main Business Overview
12.9.5 Insulet Corporation Latest Developments
12.10 Biocon
12.10.1 Biocon Company Information
12.10.2 Biocon Human Insulin Delivery System Product Offered
12.10.3 Biocon Human Insulin Delivery System Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Biocon Main Business Overview
12.10.5 Biocon Latest Developments
12.11 Roche
12.11.1 Roche Company Information
12.11.2 Roche Human Insulin Delivery System Product Offered
12.11.3 Roche Human Insulin Delivery System Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Roche Main Business Overview
12.11.5 Roche Latest Developments
12.12 Johnson & Johnson
12.12.1 Johnson & Johnson Company Information
12.12.2 Johnson & Johnson Human Insulin Delivery System Product Offered
12.12.3 Johnson & Johnson Human Insulin Delivery System Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Johnson & Johnson Main Business Overview
12.12.5 Johnson & Johnson Latest Developments
12.13 Microport
12.13.1 Microport Company Information
12.13.2 Microport Human Insulin Delivery System Product Offered
12.13.3 Microport Human Insulin Delivery System Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Microport Main Business Overview
12.13.5 Microport Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Human Insulin Delivery System Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Automatic
Table 3. Major Players of Manual
Table 4. Global Human Insulin Delivery System Sales by Type (2016-2021) & (K Units)
Table 5. Global Human Insulin Delivery System Sales Market Share by Type (2016-2021)
Table 6. Global Human Insulin Delivery System Revenue by Type (2016-2021) & ($ million)
Table 7. Global Human Insulin Delivery System Revenue Market Share by Type (2016-2021)
Table 8. Global Human Insulin Delivery System Sale Price by Type (2016-2021)
Table 9. Global Human Insulin Delivery System Sales by Application (2016-2021) & (K Units)
Table 10. Global Human Insulin Delivery System Sales Market Share by Application (2016-2021)
Table 11. Global Human Insulin Delivery System Value by Application (2016-2021)
Table 12. Global Human Insulin Delivery System Revenue Market Share by Application (2016-2021)
Table 13. Global Human Insulin Delivery System Sale Price by Application (2016-2021)
Table 14. Global Human Insulin Delivery System Sales by Company (2019-2021) & (K Units)
Table 15. Global Human Insulin Delivery System Sales Market Share by Company (2019-2021)
Table 16. Global Human Insulin Delivery System Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Human Insulin Delivery System Revenue Market Share by Company (2019-2021)
Table 18. Global Human Insulin Delivery System Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Human Insulin Delivery System Producing Area Distribution and Sales Area
Table 20. Players Human Insulin Delivery System Products Offered
Table 21. Human Insulin Delivery System Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Human Insulin Delivery System Sales by Region (2016-2021) (K Units)
Table 25. Global Human Insulin Delivery System Sales Market Share by Region (2016-2021)
Table 26. Global Human Insulin Delivery System Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Human Insulin Delivery System Revenue Market Share by Region (2016-2021)
Table 28. Americas Human Insulin Delivery System Sales by Country (2016-2021) & (K Units)
Table 29. Americas Human Insulin Delivery System Sales Market Share by Country (2016-2021)
Table 30. Americas Human Insulin Delivery System Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Human Insulin Delivery System Revenue Market Share by Country (2016-2021)
Table 32. Americas Human Insulin Delivery System Sales by Type (2016-2021) & (K Units)
Table 33. Americas Human Insulin Delivery System Sales Market Share by Type (2016-2021)
Table 34. Americas Human Insulin Delivery System Sales by Application (2016-2021) & (K Units)
Table 35. Americas Human Insulin Delivery System Sales Market Share by Application (2016-2021)
Table 36. APAC Human Insulin Delivery System Sales by Region (2016-2021) & (K Units)
Table 37. APAC Human Insulin Delivery System Sales Market Share by Region (2016-2021)
Table 38. APAC Human Insulin Delivery System Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Human Insulin Delivery System Revenue Market Share by Region (2016-2021)
Table 40. APAC Human Insulin Delivery System Sales by Type (2016-2021) & (K Units)
Table 41. APAC Human Insulin Delivery System Sales Market Share by Type (2016-2021)
Table 42. APAC Human Insulin Delivery System Sales by Application (2016-2021) & (K Units)
Table 43. APAC Human Insulin Delivery System Sales Market Share by Application (2016-2021)
Table 44. Europe Human Insulin Delivery System Sales by Country (2016-2021) & (K Units)
Table 45. Europe Human Insulin Delivery System Sales Market Share by Country (2016-2021)
Table 46. Europe Human Insulin Delivery System Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Human Insulin Delivery System Revenue Market Share by Country (2016-2021)
Table 48. Europe Human Insulin Delivery System Sales by Type (2016-2021) & (K Units)
Table 49. Europe Human Insulin Delivery System Sales Market Share by Type (2016-2021)
Table 50. Europe Human Insulin Delivery System Sales by Application (2016-2021) & (K Units)
Table 51. Europe Human Insulin Delivery System Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Human Insulin Delivery System Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Human Insulin Delivery System Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Human Insulin Delivery System Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Human Insulin Delivery System Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Human Insulin Delivery System Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Human Insulin Delivery System Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Human Insulin Delivery System Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Human Insulin Delivery System Sales Market Share by Application (2016-2021)
Table 60. Global Human Insulin Delivery System Sales Forecast by Type (2021-2026) & (K Units)
Table 61. Global Human Insulin Delivery System Sales Market Share Forecast by Type (2021-2026)
Table 62. Global Human Insulin Delivery System Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global Human Insulin Delivery System Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global Human Insulin Delivery System Sales Forecast by Application (2021-2026) & (K Units)
Table 65. Global Human Insulin Delivery System Sales Market Share Forecast by Application (2021-2026)
Table 66. Global Human Insulin Delivery System Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global Human Insulin Delivery System Revenue Market Share Forecast by Application (2021-2026)
Table 68. BD Basic Information, Human Insulin Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 69. BD Human Insulin Delivery System Product Offered
Table 70. BD Human Insulin Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 71. BD Main Business
Table 72. BD Latest Developments
Table 73. Novo Nordisk Basic Information, Human Insulin Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 74. Novo Nordisk Human Insulin Delivery System Product Offered
Table 75. Novo Nordisk Human Insulin Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 76. Novo Nordisk Main Business
Table 77. Novo Nordisk Latest Developments
Table 78. Medtronic Basic Information, Human Insulin Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 79. Medtronic Human Insulin Delivery System Product Offered
Table 80. Medtronic Human Insulin Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 81. Medtronic Main Business
Table 82. Medtronic Latest Developments
Table 83. Sanofi Basic Information, Human Insulin Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Human Insulin Delivery System Product Offered
Table 85. Sanofi Human Insulin Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 86. Sanofi Main Business
Table 87. Sanofi Latest Developments
Table 88. ELI Lilly and Company Basic Information, Human Insulin Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 89. ELI Lilly and Company Human Insulin Delivery System Product Offered
Table 90. ELI Lilly and Company Human Insulin Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 91. ELI Lilly and Company Main Business
Table 92. ELI Lilly and Company Latest Developments
Table 93. Ypsomed Holding Basic Information, Human Insulin Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 94. Ypsomed Holding Human Insulin Delivery System Product Offered
Table 95. Ypsomed Holding Human Insulin Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 96. Ypsomed Holding Main Business
Table 97. Ypsomed Holding Latest Developments
Table 98. Animas Corporation Basic Information, Human Insulin Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 99. Animas Corporation Human Insulin Delivery System Product Offered
Table 100. Animas Corporation Human Insulin Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 101. Animas Corporation Main Business
Table 102. Animas Corporation Latest Developments
Table 103. Tandem Diabetes Care Basic Information, Human Insulin Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 104. Tandem Diabetes Care Human Insulin Delivery System Product Offered
Table 105. Tandem Diabetes Care Human Insulin Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 106. Tandem Diabetes Care Main Business
Table 107. Tandem Diabetes Care Latest Developments
Table 108. Insulet Corporation Basic Information, Human Insulin Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 109. Insulet Corporation Human Insulin Delivery System Product Offered
Table 110. Insulet Corporation Human Insulin Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 111. Insulet Corporation Main Business
Table 112. Insulet Corporation Latest Developments
Table 113. Biocon Basic Information, Human Insulin Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 114. Biocon Human Insulin Delivery System Product Offered
Table 115. Biocon Human Insulin Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 116. Biocon Main Business
Table 117. Biocon Latest Developments
Table 118. Roche Basic Information, Human Insulin Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 119. Roche Human Insulin Delivery System Product Offered
Table 120. Roche Human Insulin Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 121. Roche Main Business
Table 122. Roche Latest Developments
Table 123. Johnson & Johnson Basic Information, Human Insulin Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 124. Johnson & Johnson Human Insulin Delivery System Product Offered
Table 125. Johnson & Johnson Human Insulin Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 126. Johnson & Johnson Main Business
Table 127. Johnson & Johnson Latest Developments
Table 128. Microport Basic Information, Human Insulin Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 129. Microport Human Insulin Delivery System Product Offered
Table 130. Microport Human Insulin Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 131. Microport Main Business
Table 132. Microport Latest Developments
List of Figures
Figure 1. Picture of Human Insulin Delivery System
Figure 2. Human Insulin Delivery System Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Insulin Delivery System Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Human Insulin Delivery System Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Human Insulin Delivery System Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Automatic
Figure 10. Product Picture of Manual
Figure 11. Global Human Insulin Delivery System Sales Market Share by Type in 2020
Figure 12. Global Human Insulin Delivery System Revenue Market Share by Type (2016-2021)
Figure 13. Human Insulin Delivery System Consumed in Hospitals
Figure 14. Global Human Insulin Delivery System Market: Hospitals (2016-2021) & (K Units)
Figure 15. Human Insulin Delivery System Consumed in Clinics
Figure 16. Global Human Insulin Delivery System Market: Clinics (2016-2021) & (K Units)
Figure 17. Human Insulin Delivery System Consumed in Homecare
Figure 18. Global Human Insulin Delivery System Market: Homecare (2016-2021) & (K Units)
Figure 19. Global Human Insulin Delivery System Sales Market Share by Application (2016-2021)
Figure 20. Global Human Insulin Delivery System Revenue Market Share by Application in 2020
Figure 21. Global Human Insulin Delivery System Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Human Insulin Delivery System Revenue Market Share by Company in 2020
Figure 23. Global Human Insulin Delivery System Sales Market Share by Regions (2016-2021)
Figure 24. Global Human Insulin Delivery System Revenue Market Share by Region in 2020
Figure 25. Americas Human Insulin Delivery System Sales 2016-2021 (K Units)
Figure 26. Americas Human Insulin Delivery System Revenue 2016-2021 ($ Millions)
Figure 27. APAC Human Insulin Delivery System Sales 2016-2021 (K Units)
Figure 28. APAC Human Insulin Delivery System Revenue 2016-2021 ($ Millions)
Figure 29. Europe Human Insulin Delivery System Sales 2016-2021 (K Units)
Figure 30. Europe Human Insulin Delivery System Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Human Insulin Delivery System Sales 2016-2021 (K Units)
Figure 32. Middle East & Africa Human Insulin Delivery System Revenue 2016-2021 ($ Millions)
Figure 33. Americas Human Insulin Delivery System Sales Market Share by Country in 2020
Figure 34. Americas Human Insulin Delivery System Revenue Market Share by Country in 2020
Figure 35. Americas Human Insulin Delivery System Sales Market Share by Type in 2020
Figure 36. Americas Human Insulin Delivery System Sales Market Share by Application in 2020
Figure 37. United States Human Insulin Delivery System Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Human Insulin Delivery System Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Human Insulin Delivery System Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Human Insulin Delivery System Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Human Insulin Delivery System Sales Market Share by Region in 2020
Figure 42. APAC Human Insulin Delivery System Revenue Market Share by Regions in 2020
Figure 43. APAC Human Insulin Delivery System Sales Market Share by Type in 2020
Figure 44. APAC Human Insulin Delivery System Sales Market Share by Application in 2020
Figure 45. China Human Insulin Delivery System Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Human Insulin Delivery System Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Human Insulin Delivery System Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Human Insulin Delivery System Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Human Insulin Delivery System Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Human Insulin Delivery System Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Human Insulin Delivery System Sales Market Share by Country in 2020
Figure 52. Europe Human Insulin Delivery System Revenue Market Share by Country in 2020
Figure 53. Europe Human Insulin Delivery System Sales Market Share by Type in 2020
Figure 54. Europe Human Insulin Delivery System Sales Market Share by Application in 2020
Figure 55. Germany Human Insulin Delivery System Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Human Insulin Delivery System Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Human Insulin Delivery System Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Human Insulin Delivery System Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Human Insulin Delivery System Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Human Insulin Delivery System Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Human Insulin Delivery System Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Human Insulin Delivery System Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Human Insulin Delivery System Sales Market Share by Application in 2020
Figure 64. Egypt Human Insulin Delivery System Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Human Insulin Delivery System Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Human Insulin Delivery System Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Human Insulin Delivery System Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Human Insulin Delivery System Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のヒトインスリンデリバリーシステム市場2021-2026：自動、手動(Global Human Insulin Delivery System Market Growth 2021-2026)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp